Transcatheter hepatic arterial chemoembolization combined with Kangai injection for hepatitis B virus-related hepatocellular carcinoma: A protocol for a PRISMA-compliant meta-analysis
Conclusion:
Our study will draw an objective conclusion of the efficacy of Kangai injection on curative effect (ORR and DCR), clinical symptoms, virological indicators, QoL, and immune function in patients with HBV-related HCC.
INPLASY registration number:
INPLASY202090014.
Source: Medicine - Category: Internal Medicine Tags: Research Article: Study Protocol Systematic Review Source Type: research
More News: Cancer & Oncology | Carcinoma | China Health | Databases & Libraries | Hepatitis | Hepatitis B | Hepatocellular Carcinoma | Internal Medicine | Liver Cancer | Science | Study | Virology